Yasin Keshvargar
Lawyers
Filters
Immunocore $297 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
Terns Pharmaceuticals $127.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Applied Genetic Technologies follow-on offering
We advised the underwriters on the equity offering
Precigen $129 million common stock offering
We advised the underwriters in connection with the SEC-registered equity offering
Dream Finders Homes $143.5 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Perion Network $66 million follow-on offering
We advised Perion, whose shares are listed on Nasdaq and the Tel Aviv Stock Exchange
Energizer Holdings $650 million incremental financing
We advised the joint lead arrangers and bookrunners on the incremental term facility
Generation Bio $225.4 million stock offering
We advised the underwriters on the public equity offering
Gracell Biotechnologies $209 million IPO and Nasdaq listing
We advised the underwriters on the IPO of ADSs
Energizer Holdings $950 million refinancing
Davis Polk advised (i) the joint lead arrangers and joint bookrunners and (ii) the administrative agent, in connection with a $550 million senior secured term loan facility and a $400…